PURPOSE: To compare combined trabectome-cataract surgery with cataract-alone surgery regarding their refractive and visual outcomes and complications. METHODS: In 137 eyes that underwent combined trabectome-cataract surgery, the postoperative refraction error and best visual acuity after at least 2 months postoperatively were compared to those of an in-house control group of 1,704 eyes that underwent outpatient cataract surgery. RESULTS: Combined trabectome-cataract surgery showed no significant differences regarding the biometry prediction error (BPE, mean 0.53 D vs. 0.48 D, p = 0.24) or visual outcome (BCVA, 0.81 vs. 0.78, p = 0.06). The rate of postoperative cystoid macular edema was slightly higher in the combined surgery group (2.2 % vs. 1.9 %). CONCLUSIONS: Refractive and visual outcomes were similar in both groups. Despite the slightly higher rate of postoperative macula edema, we were able to observe that the combination of these two procedures is a feasible method in glaucoma and cataract surgeries.
PURPOSE: To compare combined trabectome-cataract surgery with cataract-alone surgery regarding their refractive and visual outcomes and complications. METHODS: In 137 eyes that underwent combined trabectome-cataract surgery, the postoperative refraction error and best visual acuity after at least 2 months postoperatively were compared to those of an in-house control group of 1,704 eyes that underwent outpatientcataract surgery. RESULTS: Combined trabectome-cataract surgery showed no significant differences regarding the biometry prediction error (BPE, mean 0.53 D vs. 0.48 D, p = 0.24) or visual outcome (BCVA, 0.81 vs. 0.78, p = 0.06). The rate of postoperative cystoid macular edema was slightly higher in the combined surgery group (2.2 % vs. 1.9 %). CONCLUSIONS: Refractive and visual outcomes were similar in both groups. Despite the slightly higher rate of postoperative macula edema, we were able to observe that the combination of these two procedures is a feasible method in glaucoma and cataract surgeries.
Authors: Jonathan H Tzu; Christopher T Shah; Anat Galor; Anna K Junk; Ananth Sastry; Sarah R Wellik Journal: J Glaucoma Date: 2015-02 Impact factor: 2.503
Authors: Jens F Jordan; Thomas Wecker; Christian van Oterendorp; Alexandra Anton; Thomas Reinhard; Daniel Boehringer; Matthias Neuburger Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-10-26 Impact factor: 3.117
Authors: Hamed Esfandiari; Priyal Shah; Pooya Torkian; Ian P Conner; Joel S Schuman; Kiana Hassanpour; Nils A Loewen Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-09-26 Impact factor: 3.117
Authors: Jan Luebke; Thomas Reinhard; Hansjuergen Agostini; Daniel Boehringer; Philipp Eberwein Journal: BMC Ophthalmol Date: 2017-12-06 Impact factor: 2.209